Skip to Content
Home > Patients & Visitors > DAISY Award Nomination > Intrauterine Fetal Blood Transfusion for Rh Disease
View Additional Content In This Section
An intrauterine transfusion provides blood
Rh-positive fetus when fetal red blood cells are being
destroyed by Rh
A blood transfusion is given
to replace fetal red blood cells that are being destroyed by the
Rh-sensitized mother's immune system. This treatment
is meant to keep the fetus healthy until he or she is mature enough to be
Transfusions can be given through the fetal abdomen or,
more commonly, by delivering the blood into the umbilical vein or artery. Umbilical cord
vessel transfusion is the preferred method, because it permits better absorption
of blood and has a higher survival rate than does transfusion through the
An intrauterine fetal blood
transfusion is done in the hospital. The mother may have to stay overnight
after the procedure.
A short recovery period (approximately
1 to 3 hours) is needed to allow the mother's sedatives to wear off. If the
fetus was given medicine to prevent movement, it may be several hours until the
mother can feel the fetus moving again.
A sensitized mother's
immune system can destroy a large amount of fetal red
blood cells, causing severe
anemia. Intrauterine blood transfusions are done
In a severely affected fetus, transfusions are done every 1
to 4 weeks until the fetus is mature enough to be delivered safely.
Amniocentesis may be done to determine the maturity of the fetus's lungs before
delivery is scheduled.
Fetal survival after transfusion
depends upon the severity of the fetus's illness, the method of transfusion,
and the skill of the doctor who does the procedure. Overall, after intrauterine
transfusion through the umbilical cord:footnote 2
Intrauterine transfusions may cause:
Umbilical blood transfusions are
usually done by perinatologists at specialized centers.
Complete the special treatment information form (PDF)(What is a PDF document?) to help you understand this treatment.
Moise KJ (2009). Hemolytic disease of the fetus and newborn. In RK Creasy, R Resnik, eds., Creasy and Resnik's Maternal-Fetal Medicine, 6th ed., pp. 477–503. Philadelphia: Saunders Elsevier.
Branch DW, et al. (2008). Immunologic disorders in pregnancy. In RS Gibbs et al., eds., Danforth's Obstetrics and Gynecology, 10th ed., pp. 313–339. Philadelphia: Lippincott Williams and Wilkins.
ByHealthwise StaffPrimary Medical ReviewerSarah Marshall, MD - Family MedicineSpecialist Medical ReviewerWilliam Gilbert, MD - Maternal and Fetal Medicine
Current as ofMay 22, 2015
Current as of:
May 22, 2015
Sarah Marshall, MD - Family Medicine & William Gilbert, MD - Maternal and Fetal Medicine
To learn more about Healthwise, visit Healthwise.org.
© 1995-2015 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.